Literature DB >> 9504494

Sagittal MR of multiple sclerosis in the spinal cord: fast versus conventional spin-echo imaging.

G J Lycklama à Nijeholt1, J A Castelijns, J Weerts, H Adèr, J H van Waesberghe, C Polman, F Barkhof.   

Abstract

PURPOSE: We compared conventional spin-echo (CSE) with fast spin-echo (FSE) dual-echo MR images to determine which of these sequences was better able to depict spinal cord abnormalities in patients with multiple sclerosis (MS).
METHODS: CSE and FSE dual-echo MR images were obtained in 37 patients with MS and in six healthy control subjects, all of whom were examined on a 1.0-T MR unit with a phased-array coil and cardiac triggering. Two blinded interpreters graded the MR studies, first separately and then by consensus. Images were scored for presence of artifacts, number of focal lesions, and presence of a diffuse increase in signal intensity.
RESULTS: No abnormalities were seen in the volunteers. The CSE sequences were significantly less hindered by MR imaging artifacts than were the FSE sequences. Interobserver agreement was slightly higher for the CSE than the FSE sequences. After reaching a consensus, the observers found that both CSE and FSE techniques enabled detection of approximately the same number of focal lesions; however, in three patients, small single lesions seen on the CSE images were missed on the FSE images. Also, depiction of a diffuse increase in signal intensity was better on the CSE images. As a result, more patients had abnormal findings on the CSE sequences than on the FSE sequences (35 versus 31).
CONCLUSION: Cardiac-triggered dual-echo FSE sequences are almost as good as CSE sequences for depicting spinal MS lesions. Therefore, in cases of established spinal MS, FSE techniques may be as effective as CSE techniques. Because sensitivity for subtle abnormalities is lower with FSE imaging, CSE remains the preferred technique for patients with suspected MS of the spinal cord.

Entities:  

Mesh:

Year:  1998        PMID: 9504494      PMCID: PMC8338199     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  7 in total

Review 1.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Authors:  Àlex Rovira; Mike P Wattjes; Mar Tintoré; Carmen Tur; Tarek A Yousry; Maria P Sormani; Nicola De Stefano; Massimo Filippi; Cristina Auger; Maria A Rocca; Frederik Barkhof; Franz Fazekas; Ludwig Kappos; Chris Polman; David Miller; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2015-07-07       Impact factor: 42.937

2.  Putaminal alteration in multiple sclerosis patients with spinal cord lesions.

Authors:  Hilga Zimmermann; Hans O Rolfsnes; Swantje Montag; Janine Wilting; Amgad Droby; Eva Reuter; Joachim Gawehn; Frauke Zipp; Adriane Gröger
Journal:  J Neural Transm (Vienna)       Date:  2015-05-14       Impact factor: 3.575

Review 3.  Multiple sclerosis: the role of MR imaging.

Authors:  Y Ge
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

4.  Magnetization-transfer histogram analysis of the cervical cord in patients with multiple sclerosis.

Authors:  M Bozzali; M A Rocca; G Iannucci; C Pereira; G Comi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

5.  Axial 3D gradient-echo imaging for improved multiple sclerosis lesion detection in the cervical spinal cord at 3T.

Authors:  Arzu Ozturk; Nafi Aygun; Seth A Smith; Brian Caffo; Peter A Calabresi; Daniel S Reich
Journal:  Neuroradiology       Date:  2012-12-04       Impact factor: 2.804

6.  Negative prognostic impact of MRI spinal lesions in the early stages of relapsing-remitting multiple sclerosis.

Authors:  E D'Amico; F Patti; C Leone; S Lo Fermo; M Zappia
Journal:  Mult Scler J Exp Transl Clin       Date:  2016-02-09

Review 7.  Spinal Cord Involvement in MS and Other Demyelinating Diseases.

Authors:  Mariano Marrodan; María I Gaitán; Jorge Correale
Journal:  Biomedicines       Date:  2020-05-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.